These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 34009531)

  • 21. [A case of delirium after olanzapine intoxication].
    Steil B
    Nervenarzt; 2003 Nov; 74(11):1009-11. PubMed ID: 14598038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Post-injection delirium/sedation syndrome in patients treated with olanzapine pamoate: mechanism, incidence, and management.
    Luedecke D; Schöttle D; Karow A; Lambert M; Naber D
    CNS Drugs; 2015 Jan; 29(1):41-6. PubMed ID: 25424243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can olanzapine cause delirium in the elderly?
    Lim CJ; Trevino C; Tampi RR
    Ann Pharmacother; 2006 Jan; 40(1):135-8. PubMed ID: 16368923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Olanzapine-Associated Portal and Superior Mesenteric Vein Thrombosis.
    Mameli A; Natale L; Musu M; Finco G; Pisanu A; Marongiu F; Barcellona D
    Am J Ther; 2020; 27(4):e419-e420. PubMed ID: 31033495
    [No Abstract]   [Full Text] [Related]  

  • 25. A Case of Olanzapine-Induced Fever.
    Yang CH; Chen YY
    Psychopharmacol Bull; 2017 Jan; 47(1):45-47. PubMed ID: 28138204
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involuntary Facial Twitching in a Patient with Schizophrenia on Treatment with Long Acting Injectable Olanzapine.
    Mustafa FA; Nayar A
    Psychopharmacol Bull; 2019 Jun; 49(2):63-64. PubMed ID: 31308585
    [No Abstract]   [Full Text] [Related]  

  • 27. Follow-up study of patients treated with olanzapine pamoate in France in real-life treatment situation.
    Chartier F; Rouillon F; Berggren L; Jamonneau I; Falissard B; Llorca PM
    Encephale; 2017 Aug; 43(4):303-310. PubMed ID: 28709669
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cost-effectiveness study of olanzapine pamoate: Mirror-image analysis after one year].
    Potaufeu J; Langrée B; Drapier D; Burgot G; Marie N
    Encephale; 2019 Jun; 45(3):232-238. PubMed ID: 30579574
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delirium with visual hallucinations induced by low-dose olanzapine.
    Takeuchi N; Makino T; Nishihara M
    Psychogeriatrics; 2022 May; 22(3):415-416. PubMed ID: 35274396
    [No Abstract]   [Full Text] [Related]  

  • 30. Olanzapine: a review of rapid and long-acting parenteral formulations.
    Owen RT
    Drugs Today (Barc); 2010 Mar; 46(3):173-81. PubMed ID: 20467591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sleepwalking Is Associated With Coadministration of Olanzapine and Propranolol: A Case Report.
    Deng S; Hu J; Zhu X; Shang D; Wen Y; Qiu C
    J Clin Psychopharmacol; 2017 Oct; 37(5):622-623. PubMed ID: 28719423
    [No Abstract]   [Full Text] [Related]  

  • 32. Real-world use patterns of olanzapine long-acting injection in the United States: comparison to the recommended dosing strategy.
    Case MG; Karagianis JL; Schuh KJ; Hoffmann VP
    Curr Med Res Opin; 2013 Nov; 29(11):1533-7. PubMed ID: 23998459
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Olanzapine-induced and Risperidone-induced Leukopenia: A Case of Synergistic Adverse Reaction?
    Woon LS; Tee CK; Gan LLY; Deang KT; Chan LF
    J Psychiatr Pract; 2018 Mar; 24(2):121-124. PubMed ID: 29509183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recurrent Hyperammonemia Associated With Olanzapine.
    Wu YF
    J Clin Psychopharmacol; 2017 Jun; 37(3):366-367. PubMed ID: 28350574
    [No Abstract]   [Full Text] [Related]  

  • 35. [Treatment-resistant schizophrenia: Neutropenia with olanzapine and clozapine, and stabilization with two depot antipsychotics].
    Alba P
    Vertex; 2017 Mar; 28(132):141-144. PubMed ID: 29522636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Late-Onset Cholestatic Liver Injury During Combination Treatment With Chlorpromazine and Olanzapine: A Case Report.
    Dusi N; Comacchio C; Lasalvia A
    J Clin Psychopharmacol; 2019; 39(2):175-176. PubMed ID: 30640795
    [No Abstract]   [Full Text] [Related]  

  • 37. Efficacy of olanzapine long-acting injection in patients with acutely exacerbated schizophrenia: an insight from effect size comparison with historical oral data.
    Detke HC; Zhao F; Witte MM
    BMC Psychiatry; 2012 May; 12():51. PubMed ID: 22646847
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Olanzapine pamoate for the treatment of schizophrenia.
    Naber D
    Expert Opin Pharmacother; 2011 Mar; 12(4):627-33. PubMed ID: 21254860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dorsal hand skin hyperpigmentation following oral olanzapine (Zyprexa) use.
    Cary JH; Li BS; Maibach HI
    Contact Dermatitis; 2018 Oct; 79(4):254-255. PubMed ID: 30079483
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparison of olanzapine long-acting injection and oral olanzapine: a 2-year, randomized, open-label study in outpatients with schizophrenia.
    Detke HC; Weiden PJ; Llorca PM; Choukour M; Watson SB; Brunner E; Ascher-Svanum H
    J Clin Psychopharmacol; 2014 Aug; 34(4):426-34. PubMed ID: 24781441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.